EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)Multizentrische StudieOpen Access · CC BY-NC 3.0

Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Ednan K Bajwa iD, Dawn Cislak, Amit Kumar, Dan Li, Eric J Messina, Tom Reynders, Jean-François Denef, Vasile Corcea, Ketan P Buch, Eseng Lai iD, S Aubrey Stoch iD

International Journal of Chronic Obstructive Pulmonary Disease · 2024

DOI: 10.2147/copd.s454905 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Ednan K Bajwa und 10 weiteren Autor:innen. Beteiligte Einrichtung: MRL, Merck & Co., Inc., Rahway, NJ, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Hypertension, Pulmonary, Lung. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHypertension, PulmonaryLungHumansMaleAgedAdministration, InhalationFemaleMiddle AgedTreatment OutcomeDouble-Blind MethodAdultAged, 80 and overSoluble Guanylyl CyclaseDry Powder InhalersTime FactorsForced Expiratory VolumeEnzyme ActivatorsAntihypertensive AgentsArterial PressureVital Capacity

Stichwörter der Autor:innen

MK-5475chronic obstructive pulmonary diseasedry powder inhalerpulmonary hypertensionpulmonary vascular resistancesoluble guanylate cyclase stimulator

Substanzen

Soluble Guanylyl CyclaseEnzyme ActivatorsAntihypertensive Agents

Autor:innen und Institutionen

  • MRL, Merck & Co., Inc., Rahway, NJ, USA.
  • Translational Medicine, MSD Belgium, Brussels, Belgium.
  • PMSI Republican Clinical Hospital "T. Mosneaga", ARENSIA EM Unit, Chisinau, Republic of Moldova.
  • Department of Internal Medicine, Pulmonary and Critical Care Medicine, Lexington VA Healthcare, Lexington, KY, USA.

ORCID-Profile: Ednan K Bajwa, Eseng Lai, S Aubrey Stoch

Zitieren

APA

Bajwa, E. K., Cislak, D., Kumar, A., Li, D., Messina, E. J., Reynders, T., Denef, J. F., Corcea, V., Buch, K. P., Lai, E., & Stoch, S. A. (2024). Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s454905

Vancouver

Bajwa EK, Cislak D, Kumar A, Li D, Messina EJ, Reynders T, et al. Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s454905

BibTeX
@article{Bajwa2024,
  author = {Bajwa, Ednan K and Cislak, Dawn and Kumar, Amit and Li, Dan and Messina, Eric J and Reynders, Tom and Denef, Jean-François and Corcea, Vasile and Buch, Ketan P and Lai, Eseng and Stoch, S Aubrey},
  title = {Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  doi = {10.2147/copd.s454905}
}
Kostenlos starten →